Oral docetaxel plus encequidar - a phase 1 clinical trial.
Wang D, Hung N, Hung T, Eden K, Chan WK, Kwan R, Qin A, Chang C, Duffull S, Glue P, Jackson C.
Wang D, et al.
Cancer Chemother Pharmacol. 2024 May 30. doi: 10.1007/s00280-024-04674-4. Online ahead of print.
Cancer Chemother Pharmacol. 2024.
PMID: 38814342